Publication | Closed Access
Cyclic PNA-based compound directed against HIV-1 TAR RNA: modelling, liquid-phase synthesis and TAR bindingElectronic supplementary information (ESI) available: experimental details. See http://www.rsc.org/suppdata/ob/b3/b311775h/
25
Citations
32
References
2003
Year
Bioorganic ChemistryCyclic PnaMolecular BiologyAntiviral DrugChemical BiologyMedicinal ChemistryHuman RetrovirusAntiviral Drug DevelopmentCyclic Pna-based CompoundCyclic MoleculeBiochemistryLinear PnaLiquid-phase SynthesisHiv-1 Tar RnaVirologyOligonucleotideHivAntiviral CompoundNatural SciencesMedicineDrug Discovery
A cyclic molecule including a hexameric PNA sequence has been designed and synthesized in order to target the TAR RNA loop of HIV-1 through the formation of a "kissing complex". For comparison, its linear analogue has also been investigated. The synthesis of the cyclic and linear PNA has been accomplished following a liquid-phase strategy using mixed PNA and fully N-protected (aminoethylglycinamide) fragments. The interactions of this cyclic PNA and its linear analogue with TAR RNA have been studied and the results indicate clearly that no interaction occurs between the cyclic antisense PNA and TAR RNA, whereas a tenuous interaction has been detected with its linear PNA analogue.
| Year | Citations | |
|---|---|---|
Page 1
Page 1